Mediwound (MDWD) Announces Quarterly Results
Mediwound (NASDAQ:MDWD) released its earnings data on Thursday. The company reported ($0.28) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.15) by $0.13, AR Network reports. The company had revenue of $0.89 million for the quarter, compared to the consensus estimate of $0.19 million. During the same quarter in the prior year, the company posted ($0.36) earnings per share. The company’s quarterly revenue was up 128.2% on a year-over-year basis.
Shares of Mediwound (NASDAQ:MDWD) opened at 9.15 on Thursday. Mediwound has a one year low of $9.00 and a one year high of $19.31. The stock has a 50-day moving average of $10.58 and a 200-day moving average of $11.68. The company’s market cap is $194.9 million.
MediWound Ltd. is a fully integrated biopharmaceutical company. The Company is focused on developing, manufacturing and commercializing products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds and connective tissue disorders.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.